RenovoRx Stock Based Compensation from 2010 to 2024

RNXT Stock

USD 1.25 0.03 2.34%

RenovoRx Stock Based Compensation yearly trend continues to be comparatively stable with very little volatility. Stock Based Compensation is likely to outpace its year average in 2024. Stock Based Compensation is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. View All Fundamentals

Stock Based Compensation

First Reported

2010-12-31

Previous Quarter

1.1 M

Current Value

1.1 M

Quarterly Volatility

388.4 K

Credit Downgrade

Yuan Drop

Covid

Check RenovoRx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among RenovoRx's main balance sheet or income statement drivers, such as Net Interest Income of 116.5 K, Interest Income of 64.3 K or Depreciation And Amortization of 5.1 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. RenovoRx financial statements analysis is a perfect complement when working with RenovoRx Valuation or Volatility modules.

Check out the analysis of RenovoRx Correlation against competitors.

For more information on how to buy RenovoRx Stock please use our How to Invest in RenovoRx guide.

Latest RenovoRx's Stock Based Compensation Growth Pattern

Below is the plot of the Stock Based Compensation of RenovoRx over the last few years. It is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. RenovoRx's Stock Based Compensation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in RenovoRx's overall financial position and show how it may be relating to other accounts over time.

Stock Based Compensation

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Stock Based Compensation

Timeline

RenovoRx Stock Based Compensation Regression Statistics

	Arithmetic Mean	228,727
	Geometric Mean	80,161
	Coefficient Of Variation	169.80
	Mean Deviation	289,029
	Median	38,000
	Standard Deviation	388,388
	Sample Variance	150.8B
	Range	1.1M
	R-Value	0.72
	Mean Square Error	79.3B
	R-Squared	0.51
	Significance	0
	Slope	62,140
	Total Sum of Squares	2.1T

RenovoRx Stock Based Compensation History

	2024	1.1 M
	2023	1.1 M
	2022	644 K
	2021	147 K
	2020	50 K

Other Fundumenentals of RenovoRx

Stock Based Compensation To Revenue

RenovoRx Stock Based Compensation component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Net Invested Capital	Total Current Assets	Capital Stock	Net Working Capital	Common Stock	Current Deferred Revenue	Long Term Debt	Short Long Term Debt	Short Term Debt	Property Plant Equipment
Total Assets		0.88	0.62	-0.78	-0.15	0.07	-0.67	0.88	1.0	0.2	0.98	0.2	0.2	0.2	0.2	0.2	0.2
Total Stockholder Equity	0.88		0.91	-0.91	-0.58	0.22	-0.94	1.0	0.88	-0.2	0.88	-0.2	-0.2	-0.2	-0.2	-0.2	-0.2
Net Tangible Assets	0.62	0.91		-0.88	-0.85	0.22	-0.97	0.9	0.62	-0.57	0.62	-0.57	-0.57	-0.57	-0.57	-0.57	-0.57
Net Debt	-0.78	-0.91	-0.88		0.68	0.18	0.86	-0.94	-0.78	0.31	-0.69	0.31	0.31	0.31	0.31	0.31	0.31
Retained Earnings	-0.15	-0.58	-0.85	0.68		-0.05	0.79	-0.59	-0.15	0.8	-0.12	0.8	0.8	0.8	0.8	0.8	0.8
Accounts Payable	0.07	0.22	0.22	0.18	-0.05		-0.3	0.13	0.07	-0.06	0.28	-0.06	-0.06	-0.06	-0.06	-0.06	-0.06
Total Liab	-0.67	-0.94	-0.97	0.86	0.79	-0.3		-0.93	-0.67	0.41	-0.68	0.41	0.41	0.41	0.41	0.41	0.41
Net Invested Capital	0.88	1.0	0.9	-0.94	-0.59	0.13	-0.93		0.88	-0.2	0.86	-0.2	-0.2	-0.2	-0.2	-0.2	-0.2
Total Current Assets	1.0	0.88	0.62	-0.78	-0.15	0.07	-0.67	0.88		0.2	0.98	0.2	0.2	0.2	0.2	0.2	0.2
Capital Stock	0.2	-0.2	-0.57	0.31	0.8	-0.06	0.41	-0.2	0.2		0.19	1.0	1.0	1.0	1.0	1.0	1.0
Net Working Capital	0.98	0.88	0.62	-0.69	-0.12	0.28	-0.68	0.86	0.98	0.19		0.19	0.19	0.19	0.19	0.19	0.19
Common Stock	0.2	-0.2	-0.57	0.31	0.8	-0.06	0.41	-0.2	0.2	1.0	0.19		1.0	1.0	1.0	1.0	1.0
Current Deferred Revenue	0.2	-0.2	-0.57	0.31	0.8	-0.06	0.41	-0.2	0.2	1.0	0.19	1.0		1.0	1.0	1.0	1.0
Long Term Debt	0.2	-0.2	-0.57	0.31	0.8	-0.06	0.41	-0.2	0.2	1.0	0.19	1.0	1.0		1.0	1.0	1.0
Short Long Term Debt	0.2	-0.2	-0.57	0.31	0.8	-0.06	0.41	-0.2	0.2	1.0	0.19	1.0	1.0	1.0		1.0	1.0
Short Term Debt	0.2	-0.2	-0.57	0.31	0.8	-0.06	0.41	-0.2	0.2	1.0	0.19	1.0	1.0	1.0	1.0		1.0
Property Plant Equipment	0.2	-0.2	-0.57	0.31	0.8	-0.06	0.41	-0.2	0.2	1.0	0.19	1.0	1.0	1.0	1.0	1.0

Click cells to compare fundamentals

About RenovoRx Financial Statements

RenovoRx shareholders use historical fundamental indicators, such as Stock Based Compensation, to determine how well the company is positioned to perform in the future. Although RenovoRx investors may analyze each financial statement separately, they are all interrelated. The changes in RenovoRx's assets and liabilities, for example, are also reflected in the revenues and expenses on on RenovoRx's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

		Last Reported	Projected for Next Year
	Stock Based Compensation	1.1 M	1.1 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for RenovoRx Stock Analysis

When running RenovoRx's price analysis, check to measure RenovoRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RenovoRx is operating at the current time. Most of RenovoRx's value examination focuses on studying past and present price action to predict the probability of RenovoRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RenovoRx's price. Additionally, you may evaluate how the addition of RenovoRx to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

RenovoRx Stock Based Compensation from 2010 to 2024

Latest RenovoRx's Stock Based Compensation Growth Pattern

RenovoRx Stock Based Compensation Regression Statistics

RenovoRx Stock Based Compensation History

Other Fundumenentals of RenovoRx

RenovoRx Stock Based Compensation component correlations

About RenovoRx Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for RenovoRx Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY